Holding(s) in Company

Allergy Therapeutics PLC 27 February 2006 Allergy Therapeutics plc ("the Company") The Company received notification on 24 February 2006 that Fidelity International Limited ("FIL") and its direct and indirect subsidiaries, including Fidelity Investment Services Ltd ("FISL"), Fidelity Gestion (FIGEST), Fidelity Investments Advisory (Korea) Limited (FIA(K)L), Fidelity Investments Management (Hong Kong) Limited (FIMHK), Fidelity Pension Management ("FPM") and Fidelity Investments International (FII), investment managers for various non-US investment companies and institutional clients, are together interested in a total of 8,120,044 ordinary shares in the Company, representing approximately 12.90 per cent. of the Company's issued share capital. This shareholding is registered as follows: Shares held Management Company Nominee/Registered Name 1,366,900 FPM Northern Trust London 579,100 FPM Mellon Bank 568,100 FPM JP Morgan 543,062 FPM Bank of New York Brussels 439,684 FPM State Str Bk and Tr Co Lndn 277,700 FPM Bankers Trust London 150,100 FPM Midland Securities Services 85,300 FPM Clydesdale Bank plc 3,385,298 FISL JP Morgan 397,100 FIL Brown Bros Harrimn Ltd Lux 142,400 FIL Bank of New York Brussels 185,300 FIL JP Morgan 8,120,044 Total holding This notifiable interest also comprises the notifiable interest of Mr Edward C. Johnson III, a principal shareholder of Fidelity International Limited, and interests held on behalf of authorised unit trust schemes in the United Kingdom. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings